Tyrol 50-69 | EU-accepted1) | EU-desired1) | |
---|---|---|---|
Participation rate (after two years of observation) | 54.8% | > 70 | > 75 |
Recall for further assessment rate1) | 1.3 (318) | < 5% | < 3% |
Breast cancer detection rate | 2.0 * BIR | 1.5*BIR | > 1.5*BIR |
Interval cancer rate/Background incidence rate (BIR) 0-11 months | 18% (9) | 30% | < 30% |
Proportion of screen-detected cancers that were invasive | 91.2% (93/102) | 90% | 80%-90% |
Proportion of screen-detected cancers that were stage II+ | 33.3% (34/102)2) | 25 | < 25% |
Node-negative cancer/Total invasive cancers screen-detected | 78.2% | 75% | > 75% |
Invasive cancers ≤ 10 mm/Total invasive cancers | 32.2% | ≥25% | ≥30% |
Proportion of invasive cancers that were ≤ 15 mm in size | 70.0% | 50% | > 50% |
Time between results of screening and assessment < = 5 wd3) | 92.5% | 90% | > 90% |
Time between decision to operate and surgery < = 15 wd4) | 87.3% | 90% | > 90% |